Last reviewed · How we verify
Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.
This is an open-label, single center, non-randomized, phase I trial to evaluate the safety and efficacy of gemcitabine combined with apatinib and toripalimab in patients with the recurrent or metastatic nasopharyngeal carcinoma.
Details
| Lead sponsor | Sun Yat-sen University |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 41 |
| Start date | Sat Jun 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Nasopharyngeal Carcinoma
Interventions
- Gemcitabine combined with Aptinib and Toripalimab
Countries
China